Medley Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Kohei Takiguchi

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	15yrs
CEO ownership	19.8%
Management average tenure	1.3yrs
Board average tenure	6.3yrs

Recent management updates

Recent updates

CEO

Kohei Takiguchi (40 yo)

15yrs

Tenure

Mr. Kohei Takiguchi serves as President, Chief Executive Officer and Director at Medley,Inc. since June 2009. Prior to establishing Medley, he established Gemeinschaft, Inc. a U. S. corporation and became...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Kohei Takiguchi	CEO, President & Director	15yrs	no data	19.82% ¥ 137.3m
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	7.9yrs	no data	0.99% ¥ 6.9m
Daiki Okiyama	VP and Head of Accounting & Tax and Finance Division	1.2yrs	no data	no data
Sho Imanaka	Senior Vice President	2.6yrs	no data	no data
Masaya Hakiri	Vice President and Head of Design & Communication	less than a year	no data	no data
Noriyoshi Owari	VP & Head of Corporate Development and Finance Division	1.2yrs	no data	no data
Hayato Inakawa	Vice President & Head of Human Capital Division	1.2yrs	no data	no data
Yosuke Ishizaki	Senior VP & Head of HR Platform Business	1.4yrs	no data	no data
Takayuki Nakamura	Senior VP & Head of Medical Platform Business	2.6yrs	no data	no data
Ryusuke Inamoto	VP & CTO of HR Platform Business	1.4yrs	no data	no data
Hiroyuki Komatsu	VP & President of Pacific Medical	less than a year	no data	no data
Hiromune Shishido	CTO of Medical Platform Business & VP	less than a year	no data	no data

1.3yrs

Average Tenure

Experienced Management: 3YV's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Kohei Takiguchi	CEO, President & Director	15yrs	no data	19.82% ¥ 137.3m
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	7.9yrs	no data	0.99% ¥ 6.9m
Noboru Kotani	Independent External Director	6.3yrs	no data	0.13% ¥ 896.9k
Ryoko Nagata	External Corporate Auditor	1.3yrs	no data	no data
Masahide Kamachi	External Corporate Auditor	7.3yrs	no data	0.035% ¥ 243.5k
Shohei Omote	Full Time Auditor	8.5yrs	no data	no data
Rina Sakuraba	Independent External Director	1.3yrs	no data	no data
Reiko Nagatsuma	Independent External Director	1.3yrs	no data	no data
Keisuke Hioki	Independent External Director	1.3yrs	no data	no data

6.3yrs

Average Tenure

44yo

Average Age

Experienced Board: 3YV's board of directors are considered experienced (6.3 years average tenure).

Medley Management

Management criteria checks 1/4

Key information

Recent management updates

Medley, Inc., Annual General Meeting, Mar 26, 2024

Medley, Inc., Annual General Meeting, Mar 29, 2023

Less than half of directors are independent

Less than half of directors are independent

Medley, Inc., Annual General Meeting, Mar 25, 2022

Recent updates

Medley, Inc. to Report Q2, 2024 Results on Aug 14, 2024

First quarter 2024 earnings released: EPS: JP¥14.37 (vs JP¥11.13 in 1Q 2023)

Now 20% undervalued after recent price drop

Full year 2023 earnings released: EPS: JP¥79.52 (vs JP¥31.75 in FY 2022)

Medley, Inc. to Report Q1, 2024 Results on May 14, 2024

Full year 2023 earnings released: EPS: JP¥79.52 (vs JP¥31.75 in FY 2022)

Medley, Inc., Annual General Meeting, Mar 26, 2024

Medley, Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024

Third quarter 2023 earnings released: EPS: JP¥9.08 (vs JP¥0.37 loss in 3Q 2022)

Medley, Inc. (TSE:4480) agreed to acquire Lalune business of Ateam Wellness, K.K. for ¥500 million.

Medley, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Second quarter 2023 earnings released: EPS: JP¥47.30 (vs JP¥31.21 in 2Q 2022)

Medley, Inc. (TSE:4480) agreed to acquire Gcm.Co.,Ltd.

Medley, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Full year 2022 earnings released: EPS: JP¥31.75 (vs JP¥17.79 in FY 2021)

Full year 2022 earnings released: EPS: JP¥31.75 (vs JP¥17.79 in FY 2021)

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Medley, Inc., Annual General Meeting, Mar 29, 2023

Medley, Inc. to Report Fiscal Year 2022 Results on Feb 14, 2023

Third quarter 2022 earnings released: JP¥0.37 loss per share (vs JP¥5.33 loss in 3Q 2021)

Less than half of directors are independent

Medley, Inc. Revises Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. (TSE:4480) agreed to acquire Tenxia, inc. from Masashi Okabe and Taishi Mitsuji and others for approximately ¥260 million.

Medley, Inc. (TSE:4480) acquired Tenxia.

Medley, Inc. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥31.21 (vs JP¥21.70 in 2Q 2021)

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. to Report Q2, 2022 Results on Aug 12, 2022

First quarter 2022 earnings released: JP¥0.94 loss per share (vs JP¥4.26 loss in 1Q 2021)

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Less than half of directors are independent

Medley, Inc. to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Medley, Inc. Provides Consolidated Earning Guidance for the Year Ending December 31, 2022

Medley, Inc., Annual General Meeting, Mar 25, 2022

Third quarter 2021 earnings released: JP¥5.33 loss per share (vs JP¥2.81 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS JP¥21.72 (vs JP¥2.81 in 2Q 2020)

Medley, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2021

Medley, Inc. announced that it has received ¥5.13205 billion in funding from NTT DOCOMO, INC.

Medley, Inc. announced that it expects to receive ¥5.13205 billion in funding from NTT DOCOMO, INC.

Full year 2020 earnings released: EPS JP¥15.66 (vs JP¥14.86 loss in FY 2019)

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age